Stay updated on SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial

Sign up to get notified when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a non-clinical update to the site release metadata.
    Difference
    0.0%
    Check dated 2026-04-26T15:43:48.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T14:17:20.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; Removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T20:17:02.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T05:20:22.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no visible changes to content or functionality on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T16:38:40.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision history updated to add v3.4.1 and remove v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:19:51.000Z thumbnail image

Stay in the know with updates to SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.